Corticosteroids are a class of steroid hormones that are produced in the adrenal cortex of vertebrates, as well as the synthetic analogues of these hormones. INDICATIONS AND USAGE: id: 6c312d10-925e-cda3-e053-2a91aa0a1448 displayName: INDICATIONS & USAGE SECTION FDA Article Code: 34067-9. Triamcinolone acetonide cream 0.1% is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid responsive dermatoses. Hey CameronsMommy, Please do not use the triamcinolone cream on the baby's bottom until you talk to the doctor. This is a strong steroid that is to be used with caution and not to be covered after applied as it can increase the amount of medicine absorbed. Tennessee CoverRx Covered Drug List – Effective January 1, 2019 Form Number: TNCX1214 Revision Date: January 2019 © 2019, Magellan Health, Inc. Data Class: Public The National Asthma Education and Prevention Program Expert Panel defines low dose therapy as 300—600 mcg/day, medium dose therapy as 600—900 mcg/day, and high dose therapy as 900 mcg/day for children ages 5—11 years. NYSTATIN AND TRIAMCINOLONE ACETONIDE CREAM, USP. FOR EXTERNAL USE ONLY. NOT FOR OPHTHALMIC USE. DESCRIPTION. Nystatin and Triamcinolone Acetonide Cream, USP for dermatologic use contains the antifungal agent nystatin and the synthetic corticosteroid triamcinolone acetonide. Triamcinolone comes in ointment, cream, lotion, and aerosol (spray) in various strengths for use on the skin and as a paste for use in the mouth. Triamcinolone is cortizone. Cortizone thins the skin, your face has thin skin to start with. The lady I take care of has rosacea and here's how its treated, I put metrogel on it every day, this usually keeps it under control. Triamcinolone Acetonide (triamcinolone acetonide cream) Cream USP, 0.1%. DESCRIPTION. The topical corticosteroids constitute a class of primarily synthetic steroids used as anti-inflammatory and antipruritic agents. Preferred Drug List/Prior Authorization List Updated January 2012 - The updated list is from the November 2, 2011 P&T Committee Meeting.